βCDs have also seen effective in animal models of several other diseases known to involve endocytosis[132]: Alzheimer’s disease (APP),[133] Parkinson’s disease (α-synuclein),[134] and atherosclerosis (LDL),[135, 136] see Fig 3. The gene discussed is APP; the disease is early-onset autosomal dominant Alzheimer disease.